Targeting cellular RNA to modulate its biological function is a promising therapeutic approach, but designing small molecules to interact with a specific RNA and degrade it has been challenging.
Levels of six RNA molecules in the blood ID’d older adults likely to survive two more years. Whether it will work for other ...
Peptide conjugation techniques are advancing CNS delivery of oligonucleotides, addressing blood-brain barrier challenges and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results